Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026
Jake Scott(Stanford University), Caitlin M. Dugdale(Brown University), Meredith Arpey(University of Minnesota), Nicole C. McCann(Boston University), Katherine M. Rich(Harvard University), Ethan D. Borre(Massachusetts General Hospital), Maria E. Sundaram(Yale University), Christopher Alba(Harvard University), Jana Jarolimova(Harvard University), Nicole E. Basta(McGill University), Michael S. Abers(Albert Einstein College of Medicine), Derek Fleming(University of Minnesota), Cory Anderson(University of Minnesota), Eric A. Meyerowitz(Montefiore Medical Center), Angela K. Ulrich(University of Minnesota), Angela J Mehr(University of Minnesota), Corey D. Watts(University of Pennsylvania), Joseph Ladines-Lim(University of Pennsylvania), Harleen Marwah(Harvard University), Emily Smith(University of Minnesota), Sydney G. Redepenning(University of Minnesota), Aaron Richterman(University of Pennsylvania), Leah E. Moat(University of Minnesota), Rochelle P. Walensky(Harvard University)
Cited by 46
Related Papers
Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States
|JAMA Network Open|2020|532
Delayed production of neutralizing antibodies correlates with fatal COVID-19
|Nature Medicine|2021|263
Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
|The Lancet Infectious Diseases|2020|178